These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent advances in the diagnosis and management of malignant pleural effusions. Heffner JE, Klein JS. Mayo Clin Proc; 2008 Feb; 83(2):235-50. PubMed ID: 18241636 [Abstract] [Full Text] [Related]
3. Management of malignant pleural effusions. Spector M, Pollak JS. Semin Respir Crit Care Med; 2008 Aug; 29(4):405-13. PubMed ID: 18651358 [Abstract] [Full Text] [Related]
4. Palliative treatment of malignant pleural effusions by video-assisted thoracoscopic surgery. Benkó I, Molnár TF, Horváth OP. Acta Chir Hung; 1999 Aug; 38(2):131-3. PubMed ID: 10596313 [Abstract] [Full Text] [Related]
7. [Tetracycline pleurodesis for treatment of malignant pleural effusions. Retrospective study of 91 cases]. Martínez Moragón E, Aparicio Urtasun J, Sanchis Aldás J, Fullana Monllor J, Sanchis Moret F, Montalar Salcedo J, Marco Martínez V. Med Clin (Barc); 1993 Jul 03; 101(6):201-4. PubMed ID: 8332018 [Abstract] [Full Text] [Related]
8. Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Neragi-Miandoab S. Lung Cancer; 2006 Oct 03; 54(1):1-9. PubMed ID: 16893591 [Abstract] [Full Text] [Related]
9. [Complications of malignant tumors--malignant pleural effusions]. Eggeling S, Kaiser D. MMW Fortschr Med; 2004 May 20; 146(21):40-2. PubMed ID: 15373083 [Abstract] [Full Text] [Related]
10. Management of the malignant pleural effusion. Moores DW. Chest Surg Clin N Am; 1994 Aug 20; 4(3):481-95. PubMed ID: 7953480 [Abstract] [Full Text] [Related]
11. [Management of malignant pleural effusions]. Loddenkemper R. Pneumologie; 2005 Feb 20; 59(2):120-35. PubMed ID: 15724226 [Abstract] [Full Text] [Related]
12. Predictors of talc pleurodesis outcome in patients with malignant pleural effusions. Yildirim H, Metintas M, Ak G, Metintas S, Erginel S. Lung Cancer; 2008 Oct 20; 62(1):139-44. PubMed ID: 18403045 [Abstract] [Full Text] [Related]
13. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success. Aydogmus U, Ozdemir S, Cansever L, Sonmezoglu Y, Kocaturk CI, Bedirhan MA. Ann Surg Oncol; 2009 Mar 20; 16(3):745-50. PubMed ID: 19116753 [Abstract] [Full Text] [Related]
14. Efficacy and safety of erythromycin as sclerosing agent in patients with recurrent malignant pleural effusion. Balassoulis G, Sichletidis L, Spyratos D, Chloros D, Zarogoulidis K, Kontakiotis T, Bagalas V, Porpodis K, Manika K, Patakas D. Am J Clin Oncol; 2008 Aug 20; 31(4):384-9. PubMed ID: 18845999 [Abstract] [Full Text] [Related]
18. [VATS in malignant pleural effusions]. Cui Y, Wang J, Liu T. Zhonghua Wai Ke Za Zhi; 1997 Nov 20; 35(11):675-6. PubMed ID: 10678010 [Abstract] [Full Text] [Related]
19. Current controversies in the management of malignant pleural effusions. Azzopardi M, Porcel JM, Koegelenberg CF, Lee YC, Fysh ET. Semin Respir Crit Care Med; 2014 Dec 20; 35(6):723-31. PubMed ID: 25463163 [Abstract] [Full Text] [Related]